13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001795097
Total reported value
$544.2M
$544.2M
59 檔
56.2%
At the close of Q3 2025, Privium Fund Management B.V. disclosed equity holdings valued at approximately $544.2M, spread across 59 reported holdings.
Privium Fund Management B.V. executed strategic sector rebalancing during Q3 2025, establishing 11 new positions while fully exiting 9 holdings and trimming 11 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TSLA | Tesla Inc | Stock-Consumer Disc | 19.51% | +0.44% | +0.83% | |
| 2 | SPOT | Spotify Technology S.A. | Stock-Comm Services | 11.92% | -2.12% | -16.67% | |
| 3 | SHOP | Shopify Inc - Class A | Stock-Tech | 11.09% | -2.29% | -3.49% | |
| 4 | PLTR | Palantir Technologies Inc-a | Stock-Tech | 6.56% | -1.80% | -42.86% | |
| 5 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 5.88% | +0.71% | — | |
| 6 | SE | Sea Ltd-adr | Stock-Comm Services | 5.14% | -2.38% | EXIT | |
| 7 | COIN | Coinbase Global Inc -class A | Stock-Financials | 4.79% | -2.87% | EXIT | |
| 8 | QURE | uniQure N.V. | Stock-Other | 4.05% | +1.12% | -13.74% | |
| 9 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 2.94% | -1.28% | -22.58% | |
| 10 | IONS | Ionis Pharmaceuticals Inc | Stock-Healthcare | 2.93% | +0.13% | -6.99% | |
| 11 | NVDA | Nvidia CORP | Stock-Tech | 2.72% | +0.04% | — | |
| 12 | ✓ | Proqr Therapeutics N.v. | Stock-Other | 1.91% | +0.05% | +0.01% | |
| 13 | AMD | Advanced Micro Devices | Stock-Tech | 1.75% | +3.99% | — | |
| 14 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.57% | +0.49% | +14.41% | |
| 15 | LMND | Lemonade Inc | Stock-Financials | 1.40% | -0.10% | — | |
| 16 | BIIB | Biogen Inc | Stock-Healthcare | 1.31% | +0.25% | +153.29% | |
| 17 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 1.15% | -0.27% | — | |
| 18 | IREN | IREN Limited | Stock-Other | 1.10% | +0.58% | — | |
| 19 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 1.04% | +0.35% | -11.18% | |
| 20 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.97% | — | +8.97% | |
| 21 | ASTS | Ast Spacemobile Inc | Stock-Tech | 0.97% | -0.13% | — | |
| 22 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 0.81% | -0.09% | — | |
| 23 | URGN | UroGen Pharma Ltd. | Stock-Other | 0.71% | +0.53% | +82.70% | |
| 24 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 0.58% | -0.20% | — | |
| 25 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.47% | +0.03% | -10.51% | |
| 26 | ABVX | Abivax Sa-adr | Stock-Other | 0.46% | — | — | |
| 27 | RNAGBP | Avidity Biosciences Inc | Stock-Other | 0.42% | — | +15.22% | |
| 28 | HIMS | Hims & Hers Health Inc | Stock-Healthcare | 0.41% | +0.34% | +81.82% | |
| 29 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 0.39% | +0.16% | +30.58% | |
| 30 | ABEV | Ambev Sa-adr | Stock-Consumer Staples | 0.36% | -0.12% | +12.74% | |
| 31 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 0.35% | — | — | |
| 32 | BNTX | Biontech Se-adr | Stock-Other | 0.34% | +0.01% | +72.93% | |
| 33 | FDMT | 4d Molecular Therapeutics In | Stock-Other | 0.31% | -0.11% | — | |
| 34 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.27% | — | -52.56% | |
| 35 | BEAM | Beam Therapeutics Inc | Stock-Other | 0.27% | +0.12% | — | |
| 36 | RCKT | Rocket Pharmaceuticals Inc | Stock-Other | 0.25% | -0.03% | — | |
| 37 | MGTX | MeiraGTx Holdings plc | Stock-Other | 0.24% | +0.11% | — | |
| 38 | LXEO | Lexeo Therapeutics Inc | Stock-Other | 0.23% | -0.11% | +7.85% | |
| 39 | WVE | Wave Life Sciences Ltd. | Stock-Other | 0.22% | -0.10% | +25.41% | |
| 40 | MRNA | Moderna Inc | Stock-Healthcare | 0.22% | +0.07% | -54.56% | |
| 41 | SEA1EUR | Seabridge Gold Inc | Stock-Other | 0.21% | -0.15% | EXIT | |
| 42 | PFE | Pfizer Inc | Stock-Healthcare | 0.17% | -0.31% | EXIT | |
| 43 | ALXO | Alx Oncology Holdings Inc | Stock-Other | 0.17% | — | — | |
| 44 | VZLA | Vizsla Silver CORP | Stock-Other | 0.16% | — | -18.40% | |
| 45 | NOV | Nov Inc | Stock-Energy | 0.15% | -0.02% | — | |
| 46 | PAAS | Pan American Silver CORP | Stock-Materials | 0.13% | -0.04% | EXIT | |
| 47 | URNM | Sprott Uranium Miners ETF | ETF-Other | 0.12% | -0.04% | EXIT | |
| 48 | SLB | Slb LTD | Stock-Energy | 0.12% | -0.20% | EXIT | |
| 49 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 0.10% | — | — | |
| 50 | SD | Sandridge Energy Inc | Stock-Other | 0.10% | -0.03% | +36.11% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TSLA | Tesla Inc | +4.6% | +0.83% | Add |
| 2 | QURE | uniQure N.V. | +2.5% | -13.74% | Trim |
| 3 | ARWR | Arrowhead Pharmaceuticals In | +0.9% | -22.58% | Trim |
| 4 | IONS | Ionis Pharmaceuticals Inc | +0.8% | -6.99% | Trim |
| 5 | SHOP | Shopify Inc - Class A | +0.7% | -3.49% | Unchanged |
| 6 | NVDA | Nvidia CORP | +0.7% | — | Add |
| 7 | URGN | UroGen Pharma Ltd. | +0.4% | +82.70% | Add |
| 8 | FDMT | 4d Molecular Therapeutics In | +0.2% | — | Add |
| 9 | ✓ | Proqr Therapeutics N.v. | +0.2% | +0.01% | Add |
| 10 | RNAGBP | Avidity Biosciences Inc | +0.2% | +15.22% | Add |
| 11 | LXEO | Lexeo Therapeutics Inc | +0.1% | +7.85% | Add |
| 12 | ALXO | Alx Oncology Holdings Inc | +0.1% | — | Unchanged |
| 13 | SEA1EUR | Seabridge Gold Inc | +0.1% | +9.98% | Add |
| 14 | FATE | Fate Therapeutics Inc | +0.1% | +199.95% | Add |
| 15 | VZLA | Vizsla Silver CORP | +0.1% | -18.40% | Add |
| 16 | KRYS | Krystal Biotech Inc | 0% | +30.58% | Add |
| 17 | MGTX | MeiraGTx Holdings plc | 0% | — | Add |
| 18 | ROIV | Roivant Sciences Ltd. | 0% | — | Unchanged |
| 19 | MRK | Merck & Co. Inc. | 0% | +8.97% | Add |
| 20 | CRSP | CRISPR Therapeutics AG | -0.1% | -10.51% | Trim |
| 21 | VAL | Valaris Limited | -0.1% | -39.76% | Trim |
| 22 | ARQT | Arcutis Biotherapeutics Inc | -0.3% | -11.18% | Trim |
| 23 | MRNA | Moderna Inc | -0.3% | -54.56% | Trim |
| 24 | ACAD | Acadia Pharmaceuticals Inc | -0.4% | -52.56% | Trim |
| 25 | VRTX | Vertex Pharmaceuticals Inc | -0.5% | — | Unchanged |
| 26 | RCKT | Rocket Pharmaceuticals Inc | -0.5% | — | Unchanged |
| 27 | AMZN | Amazon.com Inc | -1.2% | — | Add |
| 28 | PLTR | Palantir Technologies Inc-a | -1.4% | -42.86% | Trim |
| 29 | SE | Sea Ltd-adr | -2% | -23.81% | Trim |
| 30 | SPOT | Spotify Technology S.A. | -9.1% | -16.67% | Trim |
| 31 | COIN | Coinbase Global Inc -class A | — | NEW | New buy |
| 32 | AMD | Advanced Micro Devices | — | NEW | New buy |
| 33 | LMND | Lemonade Inc | — | NEW | New buy |
| 34 | BIIB | Biogen Inc | — | NEW | New buy |
| 35 | SNOW | Snowflake Inc | — | EXIT | Sold out |
| 36 | NET | Cloudflare Inc - Class A | — | EXIT | Sold out |
| 37 | IREN | IREN Limited | — | NEW | New buy |
| 38 | SWTXUSD | Springworks Therapeutics Inc | — | EXIT | Sold out |
| 39 | ASTS | Ast Spacemobile Inc | — | NEW | New buy |
| 40 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 41 | HIMS | Hims & Hers Health Inc | — | NEW | New buy |
| 42 | BNTX | Biontech Se-adr | — | NEW | New buy |
| 43 | CPNG | Coupang Inc | — | EXIT | Sold out |
| 44 | ALNY | Alnylam Pharmaceuticals Inc | — | EXIT | Sold out |
| 45 | BEAM | Beam Therapeutics Inc | — | NEW | New buy |
| 46 | IMVT | Immunovant Inc | — | EXIT | Sold out |
| 47 | SLB | Slb LTD | — | NEW | New buy |
| 48 | AIG | American International Group | — | EXIT | Sold out |
| 49 | EMX | Emx Royalty CORP | — | EXIT | Sold out |
| 50 | NTLA | Intellia Therapeutics Inc | — | EXIT | Sold out |
According to official SEC Form 13F filings, Privium Fund Management B.V. reported a total U.S. public equity portfolio value of $544.2M across 59 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including TSLA, SPOT, SHOP) accounted for 56.2% of total reported equity market value during Q3 2025.
Top New Position Initiated
COIN
市值: $26.7M
Top Position Liquidated / Trimmed
SNOW
前期市值: $7.1M
During Q3 2025, Privium Fund Management B.V.'s top holdings by market value included TSLA (19.5%)、SPOT (11.9%)、SHOP (11.1%). The largest single position, TSLA, represented 19.5% of total portfolio value.
In Q3 2025, Privium Fund Management B.V. made 45 total portfolio adjustments, initiating 11 new buys, adding to 14 positions, trimming 11 holdings, and fully liquidating 9 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.